The issue is APAP for children FORTE. What was the reason for the decision of the Chief Pharmaceutical Inspector?
The Chief Pharmaceutical Inspector has decided to suspend the following medicinal product from marketing throughout the country: APAP for children FORTE, Paracetamolum, oral suspension, 40 mg/ml, 150 ml bottle:
1. series J1546, expiration date: 12.2024
2. series J1547, expiration date: 12.2024
3. series J1548, expiration date: 12.2024
4. series J1549, expiration date: 12.2024
5. series L0...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
